224 related articles for article (PubMed ID: 14761682)
1. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds.
zur Nieden NI; Kempka G; Ahr HJ
Toxicol Appl Pharmacol; 2004 Feb; 194(3):257-69. PubMed ID: 14761682
[TBL] [Abstract][Full Text] [Related]
2. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
3. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
[TBL] [Abstract][Full Text] [Related]
4. [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)].
Seiler A; Visan A; Pohl I; Genschow E; Buesen R; Spielmann H
ALTEX; 2002; 19 Suppl 1():55-63. PubMed ID: 12096331
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
[TBL] [Abstract][Full Text] [Related]
6. Trends in improving the embryonic stem cell test (EST): an overview.
Buesen R; Visan A; Genschow E; Slawik B; Spielmann H; Seiler A
ALTEX; 2004; 21(1):15-22. PubMed ID: 14976585
[TBL] [Abstract][Full Text] [Related]
7. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
[TBL] [Abstract][Full Text] [Related]
8. First steps in establishing a developmental toxicity test method based on human embryonic stem cells.
Adler S; Pellizzer C; Hareng L; Hartung T; Bremer S
Toxicol In Vitro; 2008 Feb; 22(1):200-11. PubMed ID: 17961973
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
Suzuki N; Ando S; Yamashita N; Horie N; Saito K
Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
[TBL] [Abstract][Full Text] [Related]
10. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast differentiation of murine embryonic stem cells as a model to study the embryotoxic effect of compounds.
de Jong E; van Beek L; Piersma AH
Toxicol In Vitro; 2012 Sep; 26(6):970-8. PubMed ID: 22683932
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.
Hettwer M; Reis-Fernandes MA; Iken M; Ott M; Steinberg P; Nau H
Reprod Toxicol; 2010 Aug; 30(1):113-20. PubMed ID: 20132877
[TBL] [Abstract][Full Text] [Related]
14. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
[TBL] [Abstract][Full Text] [Related]
15. Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test.
zur Nieden NI; Davis LA; Rancourt DE
Toxicol Appl Pharmacol; 2010 Sep; 247(2):91-7. PubMed ID: 20576515
[TBL] [Abstract][Full Text] [Related]
16. Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds.
de Jong E; Louisse J; Verwei M; Blaauboer BJ; van de Sandt JJ; Woutersen RA; Rietjens IM; Piersma AH
Toxicol Sci; 2009 Jul; 110(1):117-24. PubMed ID: 19401353
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
[TBL] [Abstract][Full Text] [Related]
18. Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro.
Buesen R; Genschow E; Slawik B; Visan A; Spielmann H; Luch A; Seiler A
Toxicol Sci; 2009 Apr; 108(2):389-400. PubMed ID: 19168572
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen species.
Na L; Wartenberg M; Nau H; Hescheler J; Sauer H
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):174-80. PubMed ID: 12797459
[TBL] [Abstract][Full Text] [Related]
20. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
